Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.
Protein Biomarkers May Play an Important Role in Overcoming Limitations of Circulating Tumor DNA for Screening Early-Stage ...
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
Affinity leans on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health expands liquid biopsy ...
Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...
As healthcare systems worldwide grapple with rising cancer rates, chronic diseases and limited clinical resources, ...
University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...
A new review highlights how machine learning is transforming the way scientists detect and measure organic pollutants in the ...
New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.
Imagine a screening method that’s more accurate in early detection than a mammogram and less expensive than an MRI. That’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results